Evidence map›Paper›PMID 36829040›Full record

ArticleScientific reports2023

The development of a machine learning algorithm for early detection of viral hepatitis B infection in Nigerian patients.

Busayo I Ajuwon, Alice Richardson, Katrina Roper, Meru Sheel, Rosemary Audu, Babatunde L Salako, Matthew O Bojuwoye, Ibraheem A Katibi, Brett A Lidbury

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Busayo I AjuwonNational Centre for Epidemiology and Population Health, ANU College of Health and Medicine, The Australian National University, Acton, Australian Capital Territory, Australia. busayo.ajuwon@anu.edu.au.
Alice RichardsonStatistical Support Network, The Australian National University, Acton, Australian Capital Territory, Australia.
Katrina RoperNational Centre for Epidemiology and Population Health, ANU College of Health and Medicine, The Australian National University, Acton, Australian Capital Territory, Australia.
Meru SheelSydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, New South Wales, Australia.
Rosemary AuduMicrobiology Department, Centre for Human Virology and Genomics, The Nigerian Institute of Medical Research, Yaba, Lagos State, Nigeria.
Babatunde L SalakoDirector-General's Office, The Nigerian Institute of Medical Research, Yaba, Lagos State, Nigeria.
Matthew O BojuwoyeDepartment of Medicine, University of Ilorin Teaching Hospital, Ilorin, Kwara State, Nigeria.
Ibraheem A KatibiDepartment of Medicine, University of Ilorin Teaching Hospital, Ilorin, Kwara State, Nigeria.
Brett A LidburyNational Centre for Epidemiology and Population Health, ANU College of Health and Medicine, The Australian National University, Acton, Australian Capital Territory, Australia.
Australian National University · AUNigerian Institute of Medical Research · NGUniversity of Ilorin Teaching Hospital · NGKwara State University · NGThe University of Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Access to Hepatitis B Virus (HBV) testing for people in low-resource settings has long been challenging due to the gold standard, enzyme immunoassay, being prohibitively expensive, and requiring specialised skills and facilities that are not readily available, particularly in remote and isolated laboratories. Routine pathology data in tandem with cutting-edge machine learning shows promising diagnostic potential. In this study, recursive partitioning ("trees") and Support Vector Machines (SVMs) were applied to interrogate patient dataset (n = 916) that comprised results for Hepatitis B Surface Antigen (HBsAg) and routine clinical chemistry and haematology blood tests. These algorithms were used to develop a predictive diagnostic model of HBV infection. Our SVM-based diagnostic model of infection (accuracy = 85.4%, sensitivity = 91%, specificity = 72.6%, precision = 88.2%, F1-score = 0.89, Area Under the Receiver Operating Curve, AUC = 0.90) proved to be highly accurate for discriminating HBsAg positive from negative patients, and thus rivals with immunoassay. Therefore, we propose a predictive model based on routine blood tests as a novel diagnostic for early detection of HBV infection. Early prediction of HBV infection via routine pathology markers and pattern recognition algorithms will offer decision-support to clinicians and enhance early diagnosis, which is critical for optimal clinical management and improved patient outcomes.

Indexed as

Hepatitis BHepatitis B Surface AntigensDNA, ViralEarly DiagnosisHepatitis B virusHumansMachine LearningSensitivity and SpecificityDNA, ViralHepatitis B Surface Antigens

Identifiers

PMID36829040
PMCPMC9958122
OpenAlexW4321783676

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.